Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Buy
106
+22
+26% +$1.99K ﹤0.01% 1000
2026
Q1
$6.8K Buy
84
+77
+1,100% +$6.49K ﹤0.01% 1124
2025
Q4
$517 Buy
+7
New +$495 ﹤0.01% 1217
2025
Q2
– Sell
-9
Closed -$493 – 1357
2025
Q1
$493 Buy
+9
New +$562 ﹤0.01% 1276
2024
Q3
– Sell
-8
Closed -$500 – 1304
2024
Q2
$500 Buy
+8
New +$536 ﹤0.01% 1205
2022
Q4
– Sell
-15
Closed -$1K – 974
2022
Q3
$1K Hold
15
– – ﹤0.01% 845
2022
Q2
$1K Buy
+15
New +$823 ﹤0.01% 869

Other funds holding HXL

CVA Family Office's HXL Position: Q2 2026 in Review

CVA Family Office increased its Hexcel (HXL) stake by 26% in Q2 2026, buying an estimated $1.99K and bringing the position to 106 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.

CVA Family Office first reported a position in HXL in Q2 2022 and has held it in 7 quarters since. 531 funds tracked by Wall St. Rank hold HXL as of Q2 2026.

  • CVA Family Office held 106 shares of Hexcel worth $10.6K as of Q2 2026.
  • CVA Family Office bought 22 Hexcel shares in Q2 2026, an estimated $1.99K.
  • Hexcel made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1000 holding.
  • CVA Family Office first reported a position in Hexcel in Q2 2022 and has held it in 7 quarters since.
  • 531 funds tracked by Wall St. Rank held Hexcel as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.